Navigation Links
Good liquid, bad liquid
Date:2/5/2009

Immediately after the liquid explosive bomb plot was uncovered in London in August 2006, the Department of Homeland Security's Science & Technology Directorate (S&T) looked to to find ways to not only detect liquids in baggage and on passengers, but also to figure out what those liquids are. Now, S&T-sponsored scientists at Los Alamos National Laboratory have developed a possible solution. They have successfully tested a liquid explosive detection system that may eventually have many security applications around the country. Machines ready for an operational environment remains a few years away, but the technology is promising to quickly detect liquid explosives within a few years.

Stephen Surko is the Program Manager for the research at S&T. He says, "Los Alamos has done an outstanding job in a relatively short period of time."

When S&T last reported on this technology, it was still in the conceptual phase, and went by a different name (http://www.dhs.gov/xres/programs/gc_1220462488919.shtm). Now known as MagViz, the system adapts the magnetic resonance imaging (MRI) technology, typically used by doctors to scan brains, to screen for harmful liquids, gels, and lotions.

Similar in size and shape to an X-ray machine, a working MagViz prototype was on display at the Albuquerque International Sunport in December. The system is linked to an electronic database that currently contains chemical fingerprints for 50 liquids. As shown in the images here, if a threat liquid is identified, the machine marks the container on the display screen with a red dot. Harmless liquids like water or shampoo are marked with a green dot. If MagViz cannot identify a liquid it marks the container with a yellow dot, requiring further inspection. (See the Los Alamos video for more on the science behind MagViz.)

As development of the system continues, more liquids will be ad
'/>"/>

Contact: John Verrico
john.verrico@dhs.gov
202-527-3625
US Department of Homeland Security - Science and Technology
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Research exposes the risk to infants from the chemicals used in liquid medicines
2. Videos extract mechanical properties of liquid-gel interfaces
3. Liquid crystal phases of tiny DNA molecules point up new scenario for first life on Earth
4. Researchers develop liquid crystal pharmaceuticals to fight cancer and other diseases
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Good liquid, bad liquid
(Date:6/16/2015)... GOTHENBURG, Sweden , June 16, 2015 ... 2015 from previously communicated that it will amount to at ... 390 MSEK. Due to the rapid increase in market growth ... from the previously communicated guidance that revenue for 2015 will ... 2015 will amount to approximately 2,200 MSEK. Due ...
(Date:6/12/2015)... , June 12, 2015  Securus Technologies, a ... solutions for public safety, investigation, corrections and monitoring, ... patent to electronically capture, analyze and identify participants ... recognition methods. This system can: ... an enrollment and subsequent sign-on process is actually ...
(Date:6/9/2015)... -- Research and Markets  ( http://www.researchandmarkets.com/research/xsgs2s/gesture ) has ... & Touchless Sensing Market by Technology (Touch-based & ... (Biometric & Sanitary Equipment) & by Geography - ... offering. The total gesture recognition and ... 23.55 Billion by 2020 at a high CAGR ...
Breaking Biology News(10 mins):Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 2Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 3Securus Announces Patent Issued for Authorized Presence Verification During Video Visitation 2Global Gesture Recognition & Touchless Sensing (Technology, Application & Products) Market 2015-2020 2
... bugs grow in intensive care units to develop a ... MRSA and other superbugs in the environment, scientists heard ... General Microbiologys 162nd meeting being held this week at ... a standard sampling regime to take swabs from sinks, ...
... deadliest diseases, caused by the Ebola virus, may finally ... have successfully tested several Ebola vaccines in primates and ... Dr Anthony Sanchez, from the Centers for Disease ... overview of Ebola vaccine development today (Monday 31 March ...
... Multi-Modal Biometric Identification Solution ... and Interoperability, SCHAUMBURG, Ill., March 28 ... it has been selected by the West Virginia,State ... (BIS). Motorola,s latest BIS solution features new algorithms ...
Cached Biology News:MRSA in hospital intensive care -- what's growing where? 2Vaccine for Ebola virus 2Motorola Biometric Identification System Selected by West Virginia State Police 2
(Date:6/29/2015)... KY and Manhattan, KS (PRWEB) , ... June ... ... has acquired US PATENT 7736892 B2. Under the terms of the agreement, MediVet ... Umbilical Cord Matrix Stem Cells (UCMSCs). MB-007 is currently in pre-clinical development as ...
(Date:6/29/2015)... ... ... The global microfluidics market is expected to grow at ... The market is mainly driven by the rising geriatric population, growing Asian healthcare ... adequate healthcare and research infrastructure in emerging markets, dearth of skilled professionals in ...
(Date:6/29/2015)... 2015 BioNano Genomics, Inc., the leader in ... announced today that a collaboration led by the Icahn ... creation of the first comprehensive analysis of a diploid ... for sequencing and genome mapping. This study, published today ... of the contiguous diploid human genome assembly obtained without ...
(Date:6/29/2015)... , June 29, 2015  AACC, a ... better health through laboratory medicine, is pleased to ... Clinical Chemistry , has increased to 7.9 ... This increase places Clinical Chemistry in ... reflects the significant influence of the research it ...
Breaking Biology Technology:MediVet Biologics Acquires Exclusive Patent License from Kansas State University 2MediVet Biologics Acquires Exclusive Patent License from Kansas State University 3Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 2Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 3Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 4Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 5BioNano Mapping Technology Achieves Most Contiguous Clone-free Human Genome Assembly to Date 2BioNano Mapping Technology Achieves Most Contiguous Clone-free Human Genome Assembly to Date 3AACC's Journal, Clinical Chemistry, Continues to Have Significant Impact on Medical Testing, Healthcare 2AACC's Journal, Clinical Chemistry, Continues to Have Significant Impact on Medical Testing, Healthcare 3
... , Data Reported at the 2010 ASCO ... Both Time to Tumor Progression and Overall Survival in ... Arm , QUÉBEC CITY, Jan. 25 /PRNewswire-FirstCall/ ... AEZ) (the "Company"), a late-stage drug development company specialized ...
... thin films for semiconductors in electronic devices, layers of atoms ... materials grow smooth crystals, others tend to develop bumps and ... In the online edition of the journal Science ... how atoms arrange themselves into thin films. Led by assistant ...
... As ... bright spot in terms of employment growth. But that was offset by a rough ride for ... pharmaceutical companies going into 2010 are any indication, the trouble isn,t over just yet. , ... (Vocus) January 21, 2010 -- As one of ...
Cached Biology Technology:Æterna Zentaris Partner Keryx Reports a Statistically Significant Benefit in Survival from Updated Results of a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Perifosine (KRX-0401) in the Treatment of Advanced Metastatic Colon Cancer 2Æterna Zentaris Partner Keryx Reports a Statistically Significant Benefit in Survival from Updated Results of a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Perifosine (KRX-0401) in the Treatment of Advanced Metastatic Colon Cancer 3Æterna Zentaris Partner Keryx Reports a Statistically Significant Benefit in Survival from Updated Results of a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Perifosine (KRX-0401) in the Treatment of Advanced Metastatic Colon Cancer 4Æterna Zentaris Partner Keryx Reports a Statistically Significant Benefit in Survival from Updated Results of a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Perifosine (KRX-0401) in the Treatment of Advanced Metastatic Colon Cancer 5Æterna Zentaris Partner Keryx Reports a Statistically Significant Benefit in Survival from Updated Results of a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Perifosine (KRX-0401) in the Treatment of Advanced Metastatic Colon Cancer 6Æterna Zentaris Partner Keryx Reports a Statistically Significant Benefit in Survival from Updated Results of a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Perifosine (KRX-0401) in the Treatment of Advanced Metastatic Colon Cancer 7Æterna Zentaris Partner Keryx Reports a Statistically Significant Benefit in Survival from Updated Results of a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Perifosine (KRX-0401) in the Treatment of Advanced Metastatic Colon Cancer 8Æterna Zentaris Partner Keryx Reports a Statistically Significant Benefit in Survival from Updated Results of a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Perifosine (KRX-0401) in the Treatment of Advanced Metastatic Colon Cancer 9Watching crystals grow provides clues to making smoother, defect-free thin films 2The MedZilla Report for January 2010 - Health Care Closes 2009 Strong, But Pharma Continues Shedding Jobs 2The MedZilla Report for January 2010 - Health Care Closes 2009 Strong, But Pharma Continues Shedding Jobs 3The MedZilla Report for January 2010 - Health Care Closes 2009 Strong, But Pharma Continues Shedding Jobs 4
...
TRIzol Reagents are ready-to-use monophasic solutions of phenol and guanidine isothiocyanate suitable for isolating total RNA DNA and proteins (16)....
...
...
Biology Products: